DOLUTEGRAVIR SODIUM | N204790 | VIIV HEALTHCARE CO
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ViiV Healthcare Company et al v. Aurobindo Pharma Ltd. et al 1 patentANDA 208355dolutegravir sodium | D. Del. | 2025-10-30 | Active | — |
ViiV Healthcare Company et al v. Sandoz Inc. et al 1 patentANDA 210916dolutegravir sodium | D. Del. | 2017-12-11 | Terminated 2021-08-16 | — |
VIIV HEALTHCARE COMPANY et al v. SANDOZ INC. et al 1 patentANDA 210916dolutegravir sodium | D.N.J. | 2017-12-11 | Terminated 2018-04-30 | — |
ViiV Healthcare Company et al v. Dr. Reddys Laboratories, Inc. et al 1 patentANDA 210900dolutegravir | D. Del. | 2017-12-01 | Terminated 2021-08-04 | — |
VIIV HEALTHCARE COMPANY et al v. DR. REDDYS LABORATORIES, INC. et al 1 patentANDA 210900dolutegravir | D.N.J. | 2017-12-01 | Terminated 2017-12-15 | — |
ViiV Healthcare Company et al v. Apotex Inc. et al 1 patentANDA 210908, 210909dolutegravir; abacavir; lamivudine | D. Del. | 2017-11-10 | Terminated 2021-08-16 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).